Gaspard Fiévet, an associate at the firm, has contributed to the latest issue of Échanges Internationaux, published by the French National Committee of the International Chamber of Commerce (ICC France).
In this article, Gaspard provides an in-depth analysis of the French foreign investment control regime and its recent application by the government in the Opella case, concerning Sanofi’s sale of Doliprane to an American pension fund.
To read his article and explore all contributions, visit: https://lnkd.in/evwabsEk